Company / Operating Cash Flow
QuidelOrtho Operating Cash Flow History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$105.2M
FY2025
5-year range
$83.0M / $885.3M
FY2021-FY2025
Trend
+26.7%
vs FY2024
Sector context
#102 of 158
Health Care
What the data says
At $105M, QuidelOrtho's operating cash flow ranks #102 of 158 in the Health Care sector. Operating Cash Flow returned to growth in FY2025 after 2 years of decline, reaching $105M.
Based on SEC 10-K filings.
$105M in FY2025 with a 5-year CAGR of -30.1%.
Declined from $280M to $105M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -50.8%
- 5-Year CAGR
- -30.1%
- 10-Year CAGR
- -
Sector benchmark
#102 of 158 in Health CareTop 65% of 158This company $105.2M Sector average $1.0B
▼
-89.8% below sector average
Key checks
Key Insights
- 5-year CAGR of -30.1%, indicating a declining trend.
- In FY2025, operating cash flow increased 26.7% year-over-year.
- Ranks #102 out of 158 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $105.2M | +26.7% |
| FY2024 | $83.0M | -70.4% |
| FY2023 | $280.2M | -68.3% |
| FY2022 | $885.3M | +40.6% |
| FY2020 | $629.7M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026